Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.4
Consolidated Balance Sheets - USD ($)
Oct. 31, 2024
Oct. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,271,000 $ 915,000
Short–term investments 18,653,000 22,929,000
Receivables 173,000 270,000
Prepaid expenses and other current assets 1,265,000 1,242,000
Total current assets 21,362,000 25,356,000
Operating lease right-of-use asset 229,000 166,000
Total assets 21,591,000 25,522,000
Current liabilities:    
Accounts payable 525,000 206,000
Accrued expenses 1,946,000 1,770,000
Operating lease liability 29,000 52,000
Total current liabilities 2,500,000 2,028,000
Operating lease liability, non-current 203,000 123,000
Total liabilities 2,703,000 2,151,000
Commitments and contingencies (Note 6)
Equity:    
Preferred stock, value
Common stock, par value $.01 per share; 100,000,000 shares authorized; 32,196,862 and 31,145,219 shares issued and outstanding as of October 31, 2024 and 2023, respectively 322,000 311,000
Additional paid-in capital 260,432,000 252,222,000
Accumulated deficit (240,750,000) (228,196,000)
Treasury stock, 2,000 shares at cost (6,000)
Total shareholders’ equity 19,998,000 24,337,000
Noncontrolling interest (Note 2) (1,110,000) (966,000)
Total equity 18,888,000 23,371,000
Total liabilities and equity 21,591,000 25,522,000
Series A Convertible Preferred Stock [Member]    
Equity:    
Preferred stock, value